Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Treamid in Healthy Volunteers
NCT04428593Phase 1Completed
- Sponsor
- PHARMENTERPRISES LLC
- Start
- Jan 2016
- Primary completion
- Nov 2016
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of treamid in metabolic syndrome (4 arms), sponsored by PHARMENTERPRISES LLC. Primary endpoints: Number of Adverse events per treatment arm, Changes in vital signs and 2 more. Started Jan 2016; status: completed.
02
Drugs
treamid
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT04428593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04428593.